25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BSEM (Biostem Technologies Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biostem Technologies Inc together

I guess you are interested in Biostem Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Biostem Technologies Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Biostem Technologies Inc’s Price Targets

I'm going to help you getting a better view of Biostem Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biostem Technologies Inc

I send you an email if I find something interesting about Biostem Technologies Inc.

1. Quick Overview

1.1. Quick analysis of Biostem Technologies Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biostem Technologies Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.45
Expected worth in 1 year
$12.48
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$10.03
Return On Investment
81.7%

For what price can you sell your share?

Current Price per Share
$12.28
Expected price per share
$7 - $15.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biostem Technologies Inc (5 min.)




Live pricePrice per Share (EOD)
$12.28
Intrinsic Value Per Share
$1.12 - $16.20
Total Value Per Share
$3.57 - $18.65

2.2. Growth of Biostem Technologies Inc (5 min.)




Is Biostem Technologies Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$40.8m-$983.6k$41.8m102.4%

How much money is Biostem Technologies Inc making?

Current yearPrevious yearGrowGrow %
Making money$31.8m-$8.4m$40.3m126.6%
Net Profit Margin10.6%-50.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Biostem Technologies Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biostem Technologies Inc?

Welcome investor! Biostem Technologies Inc's management wants to use your money to grow the business. In return you get a share of Biostem Technologies Inc.

First you should know what it really means to hold a share of Biostem Technologies Inc. And how you can make/lose money.

Speculation

The Price per Share of Biostem Technologies Inc is $12.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biostem Technologies Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biostem Technologies Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.45. Based on the TTM, the Book Value Change Per Share is $2.51 per quarter. Based on the YOY, the Book Value Change Per Share is $0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biostem Technologies Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.9115.6%1.9115.6%-0.51-4.1%0.332.7%0.151.2%-0.08-0.6%
Usd Book Value Change Per Share2.5120.4%2.5120.4%0.181.4%0.937.6%0.544.4%0.242.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.5120.4%2.5120.4%0.181.4%0.937.6%0.544.4%0.242.0%
Usd Price Per Share13.84-13.84-5.86-7.56-5.04-6.72-
Price to Earnings Ratio7.25-7.25--11.53--3.78--6.70--23.12-
Price-to-Total Gains Ratio5.52-5.52-32.98-21.85--11.26-15.52-
Price to Book Ratio5.65-5.65--99.44--35.48--22.74-47.40-
Price-to-Total Gains Ratio5.52-5.52-32.98-21.85--11.26-15.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.28
Number of shares81
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.510.54
Usd Total Gains Per Share2.510.54
Gains per Quarter (81 shares)203.1143.49
Gains per Year (81 shares)812.46173.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
108128020174164
20162516140348338
30243724260522512
40325032380696686
50406240500870860
6048754862010441034
7056875674012181208
8065006486013921382
9073127298015661556
10081258110017401730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%1.014.00.06.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%5.05.00.050.0%8.07.00.053.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.015.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%5.05.00.050.0%8.07.00.053.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biostem Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.5082.5080%0.178+1311%0.932+169%0.537+367%0.243+934%
Book Value Per Share--2.4492.4490%-0.059+102%0.718+241%0.294+734%0.135+1717%
Current Ratio--1.3491.3490%0.826+63%0.803+68%0.536+152%0.460+193%
Debt To Asset Ratio--0.7090.7090%1.068-34%1.305-46%2.039-65%1.561-55%
Debt To Equity Ratio--2.4342.4340%-+100%0.811+200%0.487+400%0.892+173%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--131530925.000131530925.0000%82277014.000+60%85434541.000+54%56220517.600+134%96402693.100+36%
Eps--1.9101.9100%-0.508+127%0.326+486%0.150+1176%-0.075+104%
Ev To Sales Ratio--0.4360.4360%4.931-91%3.849-89%3.981-89%251.848-100%
Free Cash Flow Per Share--1.4411.4410%-0.222+115%0.364+296%0.210+587%0.039+3566%
Free Cash Flow To Equity Per Share--1.4281.4280%-0.032+102%0.435+228%0.263+443%0.132+982%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--16.203----------
Intrinsic Value_10Y_min--1.123----------
Intrinsic Value_1Y_max--0.637----------
Intrinsic Value_1Y_min--0.058----------
Intrinsic Value_3Y_max--2.666----------
Intrinsic Value_3Y_min--0.223----------
Intrinsic Value_5Y_max--5.601----------
Intrinsic Value_5Y_min--0.439----------
Market Cap204990040.000-13%231031120.000231031120.0000%97820980.000+136%126254723.333+83%84065948.000+175%112143574.000+106%
Net Profit Margin--0.1060.1060%-0.508+581%-0.477+552%-0.542+614%-4.955+4791%
Operating Margin----0%-0%-0.2270%-0.2100%-3.6790%
Operating Ratio--0.9420.9420%1.542-39%1.431-34%1.647-43%6.211-85%
Pb Ratio5.015-13%5.6525.6520%-99.444+1859%-35.476+728%-22.744+502%47.399-88%
Pe Ratio6.429-13%7.2467.2460%-11.531+259%-3.780+152%-6.696+192%-23.121+419%
Price Per Share12.280-13%13.84013.8400%5.860+136%7.563+83%5.036+175%6.718+106%
Price To Free Cash Flow Ratio8.523-13%9.6069.6060%-26.372+375%-13.487+240%-39.216+508%-56.446+688%
Price To Total Gains Ratio4.897-13%5.5195.5190%32.978-83%21.854-75%-11.260+304%15.516-64%
Quick Ratio--1.0591.0590%0.745+42%0.603+75%0.371+185%0.212+398%
Return On Assets--0.2270.2270%-0.583+357%-0.799+452%-0.767+437%-1.146+605%
Return On Equity--0.7800.7800%-+100%0.260+200%0.156+400%-1.207+255%
Total Gains Per Share--2.5082.5080%0.178+1311%0.932+169%0.537+367%0.243+934%
Usd Book Value--40875532.00040875532.0000%-983675.000+102%11980634.667+241%4903009.800+734%2249530.500+1717%
Usd Book Value Change Per Share--2.5082.5080%0.178+1311%0.932+169%0.537+367%0.243+934%
Usd Book Value Per Share--2.4492.4490%-0.059+102%0.718+241%0.294+734%0.135+1717%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--131530925.000131530925.0000%82277014.000+60%85434541.000+54%56220517.600+134%96402693.100+36%
Usd Eps--1.9101.9100%-0.508+127%0.326+486%0.150+1176%-0.075+104%
Usd Free Cash Flow--24050084.00024050084.0000%-3709290.000+115%6078122.333+296%3500102.800+587%656014.500+3566%
Usd Free Cash Flow Per Share--1.4411.4410%-0.222+115%0.364+296%0.210+587%0.039+3566%
Usd Free Cash Flow To Equity Per Share--1.4281.4280%-0.032+102%0.435+228%0.263+443%0.132+982%
Usd Market Cap204990040.000-13%231031120.000231031120.0000%97820980.000+136%126254723.333+83%84065948.000+175%112143574.000+106%
Usd Price Per Share12.280-13%13.84013.8400%5.860+136%7.563+83%5.036+175%6.718+106%
Usd Profit--31884321.00031884321.0000%-8482984.000+127%5442158.667+486%2498372.200+1176%-1261795.600+104%
Usd Revenue--301827302.000301827302.0000%16685405.000+1709%108462636.333+178%66450077.400+354%33698518.400+796%
Usd Total Gains Per Share--2.5082.5080%0.178+1311%0.932+169%0.537+367%0.243+934%
 EOD+4 -4MRQTTM+0 -0YOY+28 -73Y+28 -75Y+29 -610Y+29 -6

3.3 Fundamental Score

Let's check the fundamental score of Biostem Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.429
Price to Book Ratio (EOD)Between0-15.015
Net Profit Margin (MRQ)Greater than00.106
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.059
Current Ratio (MRQ)Greater than11.349
Debt to Asset Ratio (MRQ)Less than10.709
Debt to Equity Ratio (MRQ)Less than12.434
Return on Equity (MRQ)Greater than0.150.780
Return on Assets (MRQ)Greater than0.050.227
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Biostem Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.136
Ma 20Greater thanMa 5012.987
Ma 50Greater thanMa 10012.989
Ma 100Greater thanMa 20012.172
OpenGreater thanClose12.300
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Biostem Technologies Inc

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Fundamental data was last updated by Penke on 2025-07-10 15:39:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Biostem Technologies Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 10.6%Β means thatΒ $0.11 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biostem Technologies Inc:

  • The MRQ is 10.6%. The company is making a huge profit. +2
  • The TTM is 10.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.6%TTM10.6%0.0%
TTM10.6%YOY-50.8%+61.4%
TTM10.6%5Y-54.2%+64.8%
5Y-54.2%10Y-495.5%+441.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6%-91.7%+102.3%
TTM10.6%-140.3%+150.9%
YOY-50.8%-196.4%+145.6%
3Y-47.7%-247.9%+200.2%
5Y-54.2%-343.3%+289.1%
10Y-495.5%-488.1%-7.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Biostem Technologies Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • 22.7% Return on Assets means thatΒ Biostem Technologies Inc generatedΒ $0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biostem Technologies Inc:

  • The MRQ is 22.7%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 22.7%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ22.7%TTM22.7%0.0%
TTM22.7%YOY-58.3%+81.0%
TTM22.7%5Y-76.7%+99.4%
5Y-76.7%10Y-114.6%+37.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.7%-11.5%+34.2%
TTM22.7%-11.5%+34.2%
YOY-58.3%-11.4%-46.9%
3Y-79.9%-11.7%-68.2%
5Y-76.7%-11.9%-64.8%
10Y-114.6%-13.7%-100.9%
4.3.1.3. Return on Equity

Shows how efficient Biostem Technologies Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • 78.0% Return on Equity means Biostem Technologies Inc generated $0.78Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biostem Technologies Inc:

  • The MRQ is 78.0%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 78.0%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ78.0%TTM78.0%0.0%
TTM78.0%YOY-+78.0%
TTM78.0%5Y15.6%+62.4%
5Y15.6%10Y-120.7%+136.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ78.0%-13.6%+91.6%
TTM78.0%-14.8%+92.8%
YOY--14.4%+14.4%
3Y26.0%-16.8%+42.8%
5Y15.6%-17.5%+33.1%
10Y-120.7%-19.5%-101.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biostem Technologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Biostem Technologies Inc is operatingΒ .

  • Measures how much profit Biostem Technologies Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biostem Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-21.0%+21.0%
5Y-21.0%10Y-367.9%+346.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY--208.5%+208.5%
3Y-22.7%-220.2%+197.5%
5Y-21.0%-342.4%+321.4%
10Y-367.9%-462.5%+94.6%
4.3.2.2. Operating Ratio

Measures how efficient Biostem Technologies Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are $0.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biostem Technologies Inc:

  • The MRQ is 0.942. The company is less efficient in keeping operating costs low.
  • The TTM is 0.942. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.942TTM0.9420.000
TTM0.942YOY1.542-0.600
TTM0.9425Y1.647-0.705
5Y1.64710Y6.211-4.563
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9422.097-1.155
TTM0.9422.684-1.742
YOY1.5423.076-1.534
3Y1.4313.524-2.093
5Y1.6474.724-3.077
10Y6.2116.445-0.234
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biostem Technologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biostem Technologies Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.35Β means the company has $1.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biostem Technologies Inc:

  • The MRQ is 1.349. The company is just able to pay all its short-term debts.
  • The TTM is 1.349. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.349TTM1.3490.000
TTM1.349YOY0.826+0.523
TTM1.3495Y0.536+0.813
5Y0.53610Y0.460+0.076
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3493.638-2.289
TTM1.3493.846-2.497
YOY0.8264.140-3.314
3Y0.8034.688-3.885
5Y0.5365.722-5.186
10Y0.4606.144-5.684
4.4.3.2. Quick Ratio

Measures if Biostem Technologies Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.06Β means the company can pay off $1.06 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biostem Technologies Inc:

  • The MRQ is 1.059. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.059. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.059TTM1.0590.000
TTM1.059YOY0.745+0.313
TTM1.0595Y0.371+0.687
5Y0.37110Y0.212+0.159
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0592.826-1.767
TTM1.0593.116-2.057
YOY0.7453.786-3.041
3Y0.6034.311-3.708
5Y0.3715.702-5.331
10Y0.2126.335-6.123
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biostem Technologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Biostem Technologies IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Biostem Technologies Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.71Β means that Biostem Technologies Inc assets areΒ financed with 70.9% credit (debt) and the remaining percentage (100% - 70.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Biostem Technologies Inc:

  • The MRQ is 0.709. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.709. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.709TTM0.7090.000
TTM0.709YOY1.068-0.359
TTM0.7095Y2.039-1.330
5Y2.03910Y1.561+0.478
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7090.327+0.382
TTM0.7090.349+0.360
YOY1.0680.332+0.736
3Y1.3050.340+0.965
5Y2.0390.346+1.693
10Y1.5610.378+1.183
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Biostem Technologies Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 243.4% means that company has $2.43 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biostem Technologies Inc:

  • The MRQ is 2.434. The company is just not able to pay all its debts with equity.
  • The TTM is 2.434. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.434TTM2.4340.000
TTM2.434YOY-+2.434
TTM2.4345Y0.487+1.947
5Y0.48710Y0.892-0.406
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4340.383+2.051
TTM2.4340.438+1.996
YOY-0.414-0.414
3Y0.8110.450+0.361
5Y0.4870.457+0.030
10Y0.8920.512+0.380
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Biostem Technologies Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Biostem Technologies Inc to theΒ Biotechnology industry mean.
  • A PE ratio of 7.25 means the investor is paying $7.25Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biostem Technologies Inc:

  • The EOD is 6.429. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.246. Based on the earnings, the company is cheap. +2
  • The TTM is 7.246. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.429MRQ7.246-0.817
MRQ7.246TTM7.2460.000
TTM7.246YOY-11.531+18.777
TTM7.2465Y-6.696+13.942
5Y-6.69610Y-23.121+16.425
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.429-2.399+8.828
MRQ7.246-2.092+9.338
TTM7.246-2.625+9.871
YOY-11.531-3.784-7.747
3Y-3.780-3.762-0.018
5Y-6.696-6.363-0.333
10Y-23.121-7.055-16.066
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biostem Technologies Inc:

  • The EOD is 8.523. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.606. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.606. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD8.523MRQ9.606-1.083
MRQ9.606TTM9.6060.000
TTM9.606YOY-26.372+35.978
TTM9.6065Y-39.216+48.822
5Y-39.21610Y-56.446+17.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.523-3.299+11.822
MRQ9.606-2.742+12.348
TTM9.606-3.801+13.407
YOY-26.372-4.402-21.970
3Y-13.487-5.140-8.347
5Y-39.216-8.483-30.733
10Y-56.446-9.296-47.150
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Biostem Technologies Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 5.65 means the investor is paying $5.65Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biostem Technologies Inc:

  • The EOD is 5.015. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.652. Based on the equity, the company is overpriced. -1
  • The TTM is 5.652. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.015MRQ5.652-0.637
MRQ5.652TTM5.6520.000
TTM5.652YOY-99.444+105.096
TTM5.6525Y-22.744+28.396
5Y-22.74410Y47.399-70.143
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.0152.113+2.902
MRQ5.6521.856+3.796
TTM5.6522.125+3.527
YOY-99.4442.454-101.898
3Y-35.4762.492-37.968
5Y-22.7443.668-26.412
10Y47.3994.364+43.035
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Total Stockholder Equity -5,802-157-5,9591,883-4,0763,093-98441,85940,876
Net Working Capital  -5,946344-5,603761-4,8422,180-2,66137,25234,591
Income before Tax  -2,369957-1,412-5,702-7,114-1,369-8,48339,09630,613
Net Income  -2,389944-1,445-5,629-7,075-1,408-8,48340,36731,884
Operating Income  -1,842237-1,606-3,076-4,682-3,097-7,77938,98031,201
Net Income from Continuing Operations  -2,369957-1,412-5,702-7,114-1,369-8,48340,36731,884



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets140,376
Total Liabilities99,500
Total Stockholder Equity40,876
 As reported
Total Liabilities 99,500
Total Stockholder Equity+ 40,876
Total Assets = 140,376

Assets

Total Assets140,376
Total Current Assets133,761
Long-term Assets6,615
Total Current Assets
Cash And Cash Equivalents 22,833
Net Receivables 104,980
Inventory 1,824
Other Current Assets 2,874
Total Current Assets  (as reported)133,761
Total Current Assets  (calculated)132,511
+/- 1,250
Long-term Assets
Property Plant Equipment 1,966
Goodwill 245
Intangible Assets 224
Long-term Assets  (as reported)6,615
Long-term Assets  (calculated)2,435
+/- 4,180

Liabilities & Shareholders' Equity

Total Current Liabilities99,170
Long-term Liabilities330
Total Stockholder Equity40,876
Total Current Liabilities
Short Long Term Debt 3,958
Accounts payable 5,290
Other Current Liabilities 711
Total Current Liabilities  (as reported)99,170
Total Current Liabilities  (calculated)9,959
+/- 89,211
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt287
Long-term Liabilities  (as reported)330
Long-term Liabilities  (calculated)287
+/- 43
Total Stockholder Equity
Total Stockholder Equity (as reported)40,876
Total Stockholder Equity (calculated)0
+/- 40,876
Other
Capital Stock17
Common Stock Shares Outstanding 16,643
Net Invested Capital 44,983
Net Working Capital 34,591
Property Plant and Equipment Gross 3,163



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312011-12-312010-12-312009-12-311999-12-31
> Total Assets 
6,070
2,046
2,696
3,475
440
2,936
2,738
3,033
4,300
3,154
2,668
2,672
3,466
14,560
140,376
140,37614,5603,4662,6722,6683,1544,3003,0332,7382,9364403,4752,6962,0466,070
   > Total Current Assets 
2,516
169
80
82
51
785
290
231
1,958
1,067
851
939
1,487
12,599
133,761
133,76112,5991,4879398511,0671,9582312907855182801692,516
       Cash And Cash Equivalents 
35
169
27
26
51
412
166
48
1,176
141
101
340
772
239
22,833
22,8332397723401011411,1764816641251262716935
       Net Receivables 
202
0
53
56
0
152
17
19
185
79
12
300
37
11,372
104,980
104,98011,3723730012791851917152056530202
       Inventory 
448
0
0
0
0
220
94
147
415
565
571
260
395
659
1,824
1,824659395260571565415147942200000448
   > Long-term Assets 
0
0
0
0
0
0
0
2,781
2,342
2,087
1,819
1,733
1,980
1,961
6,615
6,6151,9611,9801,7331,8192,0872,3422,7810000000
       Property Plant Equipment 
444
1,816
2,211
1,936
91
1,342
1,681
1,678
0
1,581
1,354
1,278
1,373
1,369
1,966
1,9661,3691,3731,2781,3541,58101,6781,6811,342911,9362,2111,816444
       Goodwill 
3,045
0
0
0
298
630
192
562
465
465
465
245
245
245
245
2452452452454654654655621926302980003,045
       Long Term Investments 
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000055
       Intangible Assets 
0
61
87
78
0
154
553
427
0
0
0
210
363
348
224
22434836321000042755315407887610
       Long-term Assets Other 
0
0
0
0
0
0
0
0
41
41
0
0
0
0
0
00000414100000000
> Total Liabilities 
7,965
0
0
0
66
1,292
2,257
1,570
5,972
7,091
8,301
8,466
7,416
15,544
99,500
99,50015,5447,4168,4668,3017,0915,9721,5702,2571,292660007,965
   > Total Current Liabilities 
5,572
0
0
0
54
792
1,757
1,098
5,223
5,891
6,797
6,541
6,328
15,260
99,170
99,17015,2606,3286,5416,7975,8915,2231,0981,757792540005,572
       Short-term Debt 
3,640
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000003,640
       Short Long Term Debt 
3,640
0
0
0
0
0
0
955
4,393
3,786
3,994
3,000
4,042
4,446
3,958
3,9584,4464,0423,0003,9943,7864,3939550000003,640
       Accounts payable 
4,082
0
0
0
24
781
1,307
562
346
688
608
647
570
1,031
5,290
5,2901,0315706476086883465621,307781240004,082
       Other Current Liabilities 
141
0
0
0
20
11
17
36
0
154
193
337
159
289
711
711289159337193154036171120000141
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
750
1,200
1,504
1,925
1,088
284
330
3302841,0881,9251,5041,20075000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
120
51
0
0
005112000000000000
       Deferred Long Term Liability 
0
0
0
0
0
14
0
0
0
0
0
0
0
0
0
0000000001400000
> Total Stockholder Equity
-1,894
2,045
2,696
3,474
373
1,644
485
1,489
-1,611
-4,086
-5,802
-5,959
-4,076
-984
40,876
40,876-984-4,076-5,959-5,802-4,086-1,6111,4894851,6443733,4742,6962,045-1,894
   Common Stock
15
106
228
290
492
1,252
1,454
2,908
0
0
0
10
12
0
0
0012100002,9081,4541,25249229022810615
   Retained Earnings Total Equity000000000000000
   Accumulated Other Comprehensive Income 000000000000000
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
12
0
0
0
0
0
-1,225
-857
0
0
0
0
0
0
0
0000000-857-1,2250000012



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue301,827
Cost of Revenue-13,746
Gross Profit288,081288,081
 
Operating Income (+$)
Gross Profit288,081
Operating Expense-270,627
Operating Income31,20117,455
 
Operating Expense (+$)
Research Development1,911
Selling General Administrative254,749
Selling And Marketing Expenses0
Operating Expense270,627256,660
 
Net Interest Income (+$)
Interest Income0
Interest Expense-587
Other Finance Cost-0
Net Interest Income-587
 
Pretax Income (+$)
Operating Income31,201
Net Interest Income-587
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,61331,201
EBIT - interestExpense = -587
31,884
32,472
Interest Expense587
Earnings Before Interest and Taxes (EBIT)031,201
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax30,613
Tax Provision--1,271
Net Income From Continuing Ops31,88431,884
Net Income31,884
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0587
 

Technical Analysis of Biostem Technologies Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biostem Technologies Inc. The general trend of Biostem Technologies Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biostem Technologies Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biostem Technologies Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biostem Technologies Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 14.52 < 15.45 < 15.50.

The bearish price targets are: 10.41 > 10 > 7.

Know someone who trades $BSEM? Share this with them.πŸ‘‡

Biostem Technologies Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biostem Technologies Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biostem Technologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biostem Technologies Inc. The current macd is -0.23169705.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biostem Technologies Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biostem Technologies Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biostem Technologies Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biostem Technologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiostem Technologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biostem Technologies Inc. The current adx is 25.38.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biostem Technologies Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Biostem Technologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biostem Technologies Inc. The current sar is 13.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biostem Technologies Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biostem Technologies Inc. The current rsi is 44.14. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Biostem Technologies Inc Daily Relative Strength Index (RSI) ChartBiostem Technologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biostem Technologies Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biostem Technologies Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biostem Technologies Inc Daily Stochastic Oscillator ChartBiostem Technologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biostem Technologies Inc. The current cci is -60.87602079.

Biostem Technologies Inc Daily Commodity Channel Index (CCI) ChartBiostem Technologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biostem Technologies Inc. The current cmo is -17.22904661.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biostem Technologies Inc Daily Chande Momentum Oscillator (CMO) ChartBiostem Technologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biostem Technologies Inc. The current willr is -65.51724138.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biostem Technologies Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biostem Technologies Inc Daily Williams %R ChartBiostem Technologies Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Biostem Technologies Inc.

Biostem Technologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biostem Technologies Inc. The current atr is 0.76684166.

Biostem Technologies Inc Daily Average True Range (ATR) ChartBiostem Technologies Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biostem Technologies Inc. The current obv is 884,090.

Biostem Technologies Inc Daily On-Balance Volume (OBV) ChartBiostem Technologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biostem Technologies Inc. The current mfi is 22.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biostem Technologies Inc Daily Money Flow Index (MFI) ChartBiostem Technologies Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biostem Technologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Biostem Technologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biostem Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.136
Ma 20Greater thanMa 5012.987
Ma 50Greater thanMa 10012.989
Ma 100Greater thanMa 20012.172
OpenGreater thanClose12.300
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biostem Technologies Inc with someone you think should read this too:
  • Are you bullish or bearish on Biostem Technologies Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biostem Technologies Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biostem Technologies Inc

I send you an email if I find something interesting about Biostem Technologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biostem Technologies Inc.

Receive notifications about Biostem Technologies Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.